NAUT Stock Analysis: Buy, Sell, or Hold?
NAUT - Nautilus Biotechnolgy, Inc. Common Stock
$1.95
0.01 (0.52%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
23d
Smart Money Accumulation
NAUT is down 5.8% this week, but smart money is accumulating calls. Top strike: $2.5 2026-03-20 with 1,179 OI. Call ratio: 100% View Scanner →
Strength: 7.9/10
Get Alerted When NAUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NAUT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NAUT is currently trading at $1.95, which is considered slightly low relative to its 30-day fair value range of $1.90 to $2.14.
Technical Outlook: Technically, NAUT is in a strong uptrend. Immediate support is located at $1.75, while resistance sits at $2.30.
Market Sentiment: NAUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $2.50 (+28.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NAUT is in a strong uptrend. Immediate support is located at $1.75, while resistance sits at $2.30.
Market Sentiment: NAUT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $2.50 (+28.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.90 -
$2.14
Company Quality Score
49/100
(HOLD)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
Protect Your Profits
Holding NAUT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.2% below Wall St target ($2.50)
- CAUTION: Recommendation downgraded due to -5.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.90 -
$2.14
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.50
(25.8%)
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.30
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.20
Wall Street Target
$2.50
(+28.2%)
Last updated: February 01, 2026 8:07 AM ET
Data refreshes hourly during market hours. Next update: 9:07 AM
Data refreshes hourly during market hours. Next update: 9:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAUT showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Sujal M Patel
BUY
83500 shares
2025-09-08
Sujal M Patel
BUY
116500 shares
2025-09-05
Matthew B Murphy
BUY
20000 shares
2025-09-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced NAUT Option Strategies
Professional options setups generated by AI based on today's NAUT price and gamma walls.
